_1777370193195_831968492.png&w=48&q=75){kind=small}
Ozempic and muscle loss risk
A new drug called apitegromab shows potential to prevent muscle loss associated with obesity medications like Ozempic, Wegovy, and Mounjaro. In a six-month clinical trial, participants who received apitegromab alongside weight-loss drugs maintained significantly more muscle mass than those given a placebo. Experts say further research is needed before recommending its widespread use.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)